Immunoglobulin A nephropathy
Learn about Immunoglobulin A nephropathy, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Berger disease; IgA nephropathy
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis, onset, prevalence. Ask the treating doctor about these.
What it is
From: Orphanet
A rare glomerular disease, histologically characterized by glomerular mesangial deposits of IgA, often accompanied by IgG and complement C3 as well as mesangioproliferative changes, clinically mostly manifesting as oligosymptomatic glomerulonephritis, possibly infection-triggered macrohematuria and a variable course ranging from spontaneous remission to slow or rarely rapid progression to kidney failure.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Acute kidney injury · Frequent (79-30%)
- Sudden loss of renal function, as manifested by decreased urine production, and a rise in serum creatinine or blood urea nitrogen concentration (azotemia).
- IgA deposition in the glomerulus · Frequent (79-30%)
- The presence of immunoglobulin A deposits in the glomerulus.
- Macroscopic hematuria · Frequent (79-30%)
- Hematuria that is visible upon inspection of the urine.
- Microscopic hematuria · Frequent (79-30%)
- Microscopic hematuria detected by dipstick or microscopic examination of the urine.
- Mild proteinuria · Frequent (79-30%)
- Mildly increased levels of protein in the urine (150-500 mg per day in adults).
- Ascites · Occasional (29-5%)
- Accumulation of fluid in the peritoneal cavity (between the layers of the peritoneum that lines the abdomen).
- Celiac disease · Occasional (29-5%)
- Celiac disease (CD) is an autoimmune condition affecting the small intestine, triggered by the ingestion of gluten, the protein fraction of wheat, barley, and rye. Clinical manifestations of CD are highly variable and include both gastrointestinal and non-gastrointestinal features. The hallmark of CD is an immune-mediated enteropathy. This term is included because the occurrence of CD is seen as a feature of a number of other diseases.
- Cirrhosis · Occasional (29-5%)
- A chronic disorder of the liver in which liver tissue becomes scarred and is partially replaced by regenerative nodules and fibrotic tissue resulting in loss of liver function.
- Crackles · Occasional (29-5%)
- Crackles are discontinuous, explosive, and nonmusical adventitious lung sounds normally heard in inspiration and sometimes during expiration. Crackles are usually classified as fine and coarse crackles based on their duration, loudness, pitch, timing in the respiratory cycle, and relationship to coughing and changing body position.
- Foamy urine · Occasional (29-5%)
- Urine has an increased amount of frothy fine bubbles.
- Glomerular crescent formation · Occasional (29-5%)
- Glomerular crescent refers hyperplastic lesions involving 10% or more of the circumference of Bowman's capsule. Crescents can be composed of a variable mixture of epithelial/leukocyte hypercellularity, fibrous matrix, and fibrin.
- Glomerulonephritis · Occasional (29-5%)
- Inflammation of the renal glomeruli.
- Hypertension · Occasional (29-5%)
- The presence of chronic increased pressure in the systemic arterial system.
- Increased circulating IgA level · Occasional (29-5%)
- An abnormally increased level of immunoglobulin A in blood.
Other findings in the same source
From: Orphanet
Additional reported features include Renal insufficiency (Occasional (29-5%)); Facial edema (Occasional (29-5%)); Nephrotic range proteinuria (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.
Which doctor should you see?
The suggested department for discussing Immunoglobulin A nephropathy is Nephrology, with a nephrologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- How is kidney function being assessed over time?
- Are any current medicines or supplements relevant to kidney safety?
- Is there an individual recommendation about fluids, diet or blood pressure?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Immunoglobulin A nephropathy. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by a nephrologist. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Immunoglobulin A nephropathy — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1253.